Cannara Biotech Inc.

TSXV:LOVE Rapporto sulle azioni

Cap. di mercato: CA$69.3m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Cannara Biotech Gestione

Gestione criteri di controllo 3/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Zohar Krivorot

Amministratore delegato

CA$300.0k

Compenso totale

Percentuale dello stipendio del CEO100.0%
Mandato del CEO5.6yrs
Proprietà del CEOn/a
Durata media del management3.7yrs
Durata media del Consiglio di amministrazione5.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Cannara Biotech Inc.'s (CVE:LOVE) 33% Price Boost Is Out Of Tune With Earnings

Aug 22
Cannara Biotech Inc.'s (CVE:LOVE) 33% Price Boost Is Out Of Tune With Earnings

Cannara Biotech (CVE:LOVE) Shareholders Will Want The ROCE Trajectory To Continue

Aug 21
Cannara Biotech (CVE:LOVE) Shareholders Will Want The ROCE Trajectory To Continue

Does Cannara Biotech (CVE:LOVE) Have A Healthy Balance Sheet?

Jul 14
Does Cannara Biotech (CVE:LOVE) Have A Healthy Balance Sheet?

Cannara Biotech Inc.'s (CVE:LOVE) Prospects Need A Boost To Lift Shares

May 09
Cannara Biotech Inc.'s (CVE:LOVE) Prospects Need A Boost To Lift Shares

Here's Why We Think Cannara Biotech (CVE:LOVE) Might Deserve Your Attention Today

Feb 28
Here's Why We Think Cannara Biotech (CVE:LOVE) Might Deserve Your Attention Today

Investor Optimism Abounds Cannara Biotech Inc. (CVE:LOVE) But Growth Is Lacking

Jan 24
Investor Optimism Abounds Cannara Biotech Inc. (CVE:LOVE) But Growth Is Lacking

Cannara Biotech's (CVE:LOVE) Earnings May Just Be The Starting Point

Dec 18
Cannara Biotech's (CVE:LOVE) Earnings May Just Be The Starting Point

Is Cannara Biotech (CVE:LOVE) A Risky Investment?

Jul 29
Is Cannara Biotech (CVE:LOVE) A Risky Investment?

Cannara Biotech Inc.'s (CVE:LOVE) Business Is Yet to Catch Up With Its Share Price

Apr 10
Cannara Biotech Inc.'s (CVE:LOVE) Business Is Yet to Catch Up With Its Share Price

Here's Why Cannara Biotech (CVE:LOVE) Has A Meaningful Debt Burden

Jan 26
Here's Why Cannara Biotech (CVE:LOVE) Has A Meaningful Debt Burden

Cannara Biotech's (CVE:LOVE) Earnings Aren't As Good As They Appear

Jan 27
Cannara Biotech's (CVE:LOVE) Earnings Aren't As Good As They Appear

Cannara Biotech (CVE:LOVE) Has A Somewhat Strained Balance Sheet

Dec 10
Cannara Biotech (CVE:LOVE) Has A Somewhat Strained Balance Sheet

Here's Why Cannara Biotech (CSE:LOVE) Can Afford Some Debt

Mar 16
Here's Why Cannara Biotech (CSE:LOVE) Can Afford Some Debt

Can You Imagine How Cannara Biotech's (CSE:LOVE) Shareholders Feel About The -6.5% Share Price Increase?

Jan 22
Can You Imagine How Cannara Biotech's (CSE:LOVE) Shareholders Feel About The -6.5% Share Price Increase?

Have Insiders Been Buying Cannara Biotech Inc. (CSE:LOVE) Shares?

Dec 18
Have Insiders Been Buying Cannara Biotech Inc. (CSE:LOVE) Shares?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Zohar Krivorot rispetto agli utili di Cannara Biotech?
DataCompenso totaleStipendioGuadagni aziendali
May 31 2024n/an/a

CA$5m

Feb 29 2024n/an/a

CA$6m

Nov 30 2023n/an/a

CA$9m

Aug 31 2023CA$300kCA$300k

CA$7m

May 31 2023n/an/a

CA$5m

Feb 28 2023n/an/a

CA$3m

Nov 30 2022n/an/a

CA$3m

Aug 31 2022CA$75kCA$75k

CA$2m

May 31 2022n/an/a

CA$884k

Feb 28 2022n/an/a

CA$1m

Nov 30 2021n/an/a

CA$1m

Aug 31 2021n/an/a

-CA$2m

May 31 2021n/an/a

-CA$7m

Feb 28 2021n/an/a

-CA$11m

Nov 30 2020n/an/a

-CA$13m

Aug 31 2020CA$92kCA$92k

-CA$12m

May 31 2020n/an/a

-CA$12m

Feb 29 2020n/an/a

-CA$12m

Nov 30 2019n/an/a

-CA$13m

Aug 31 2019CA$150kCA$150k

-CA$12m

Compensazione vs Mercato: La retribuzione totale di Zohar ($USD 220.00K ) è circa la media per le aziende di dimensioni simili nel mercato Canadian ($USD 176.00K ).

Compensazione vs guadagni: La retribuzione di Zohar è aumentata di oltre il 20% nell'ultimo anno.

AMMINISTRATORE DELEGATO

Zohar Krivorot (47 yo)

5.6yrs

Mandato

CA$300,000

Compensazione

Mr. Zohar Krivorot serves as Chief Executive Officer of Cannara Biotech Inc. since 2019, Director since December 31, 2018 and is its Founder, Chairman of the Board. He served as President at Cannara Biotec...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Zohar Krivorot
CEO & Chairman5.6yrsCA$300.00kNessun dato
Nicholas Sosiak
Chief Financial Officer3.8yrsCA$240.00k0.031%
CA$ 21.5k
Avi Krivorot
Chief Technology Officerno dataCA$300.00k0.052%
CA$ 36.4k
Anthony Manouk
VP of Compliance & GMno dataCA$160.00k0.0049%
CA$ 3.4k
Brian Sherman
General Counsel & VP Legal Affairsno dataNessun dato0.019%
CA$ 12.9k
David Abitbol
Vice President of Marketing3.6yrsNessun datoNessun dato
Scott Carroll
Vice President of Marketing & Salesno dataNessun dato0.0034%
CA$ 2.4k
France Landry
Vice President of Human Resources1.8yrsNessun datoNessun dato
Julia Bouvet
Chief of Staffno dataNessun datoNessun dato
Etienne Ledoux
Executive Officerno dataCA$300.00kNessun dato

3.7yrs

Durata media

Gestione esperta: Il team dirigenziale di LOVE è considerato esperto (durata media dell'incarico 3.7 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Zohar Krivorot
CEO & Chairman5.7yrsCA$300.00kNessun dato
Jacob Kay
Independent Director5.3yrsCA$20.00k0.24%
CA$ 168.6k
Donald Olds
Independent Lead Director3.8yrsCA$32.50k1.34%
CA$ 932.2k
Derek Stern
Independent Director5.7yrsNessun dato0.42%
CA$ 289.5k
Mary Durocher
Independent Director4.3yrsCA$17.50kNessun dato

5.3yrs

Durata media

60.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di LOVE sono considerati esperti (durata media dell'incarico 5.3 anni).